Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin

Experimental Neurology

Volumn 250, Issue , 2013, Pages 43-51

  Boroujerdi, Amin ^a   Welser Alves, Jennifer V ^a   Milner, Richard ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

5 integrin; Angiogenesis; Blood brain barrier (BBB); Endothelial cells; Experimental autoimmune encephalomyelitis (EAE); Fibronectin; Vascular remodeling

Indexed keywords

FIBRONECTIN; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 5;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN BLOOD VESSEL; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL PROLIFERATION; CERVICAL SPINAL CORD; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION; TUBERCULOSIS; UPREGULATION; VASCULAR REMODELING; VENULE; WHITE MATTER;

Α5 INTEGRIN; ANGIOGENESIS; BLOOD-BRAIN BARRIER (BBB); ENDOTHELIAL CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE); FIBRONECTIN; VASCULAR REMODELING;

ANIMALS; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; FIBRONECTINS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA5BETA1; MICE; MICE, INBRED C57BL; SPINAL CORD;

EID: 84885342334     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.009     Document Type: Article

References (45)

1. Adams R.A., Bauer J., Flick M.J., Sikorski S.L., Nuriel T., Lassmann H., Degen J.L., Akassoglou K. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J. Exp. Med. 2007, 204:571-582.
2. Astrof S., Hynes R.O. Fibronectins in vascular development. Angiogenesis 2009, 12:165-175.
3. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 1997, 75:165-173.
4. Crocker S.J., Whitmire J.K., Frausto R.F., Chertboonmuang P., Soloway P.D., Whitton J.L., Campbell I.L. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am. J. Pathol. 2006, 169:2104-2116.
5. Dore-Duffy P., Wencel M., Katyshev V., Cleary K. Chronic mild hypoxia ameliorates chronic inflammatory activity in myelin oligodendrocyte glycoprotein (MOG) peptide induced experimental autoimmune encephalomyelitis (EAE). Adv. Exp. Med. Biol. 2011, 701:165-173.
6. ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994, 343:271-275.
7. Gay D., Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques. Brain 1991, 114:557-572.
8. Gidday J.M., Gasche Y.G., Copin J.C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., Park T.S. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H558-H568.
9. Greenberg D.A., Jin K. From angiogenesis to neuropathology. Nature 2005, 438:954-959.
10. Holley J.E., Newcombe J., Whatmore J.L., Gutowski N.J. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci. Lett. 2010, 470:65-70.
11. Kelly M.A., Shuaib A., Todd K.G. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp. Neurol. 2006, 200:38-49.
12. Kim S., Bell K., Mousa S.A., Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 2000, 156:1345-1362.
13. Kirk J., Plumb J., Mirakhur M., McQuaid S. Tight junction abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201:319-327.
14. Kirk S., Frank J.A., Karlik S.J. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?. J. Neurol. Sci. 2004, 217:125-130.
15. LaManna J.C., Vendel L.M., Farrell R.M. Brain adaptation to chronic hypobaric hypoxia in rats. J. Appl. Physiol. 1992, 72:2238-2243.
16. Lassmann H. Multiple sclerosis pathology. McAlpine's Multiple Sclerosis 1998, 323-358. Churchill Livingstone. 3rd ed. A. Compston (Ed.).
17. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J. Neurol. Sci. 2003, 206:187-191.
18. Li L., Welser J.V., Dore-Duffy P., Del Zoppo G.J., LaManna J.C., Milner R. In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the α6β4 integrin and dystroglycan. Glia 2010, 58:1157-1167.
19. Li L., Welser J.V., Milner R. Absence of the αvβ3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in α5β1 integrin expression. J. Cereb. Blood Flow Metab. 2010, 30:1031-1043.
20. Li L., Liu F., Welser-Alves J.V., McCullough L.D., Milner R. Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra. Exp. Neurol. 2012, 233:283-291.
21. Li L., Welser-Alves J.V., van der Flier A., Boroujerdi A., Hynes R.O., Milner R. An angiogenic role for the α5β1 integrin in promoting endothelial cell proliferation during cerebral hypoxia. Exp. Neurol. 2012, 237:46-54.
22. Ludwin S.K., Henry J.M., McFarland H.F. Vascular proliferation and angiogenesis in MS: clinical and pathogenic implications. J. Neuropathol. Exp. Neurol. 2001, 60:505.
23. Maier J., Kincaid C.L., Pagenstecher A., Campbell I.L. Regulation of signal transducer and activator of transcription (STAT) and suppressor of cytokine signaling (SOCS) gene expression in the brain of mice with astrocyte-targeted production of IL-12 and experimental autoimmune encephalomyelitis. Am. J. Pathol. 2002, 160:271-288.
24. Miller B.A., Perez R.S., Shah A.R., Gonzales E.R., Park T.S., Gidday J.M. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 2001, 12:1663-1669.
25. Milner R., Campbell I.L. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6 beta1 integrin. J. Neurosci. 2002, 22:1562-1572.
26. Milner R., Crocker S.J., Hung S., Wang X., Frausto R.F., Del Zoppo G.J. Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins α5β1 and αvβ5. J. Immunol. 2007, 178:8158-8167.
27. Milner R., Hung S., Erokwu B., Dore-Duffy P., LaManna J.C., del Zoppo G.J. Increased expression of fibronectin and the α5β1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol. Cell. Neurosci. 2008, 38:43-52.
28. Milner R., Hung S., Wang X., Berg G., Spatz M., del Zoppo G. Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit. Stroke 2008, 39:191-197.
29. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 2002, 61:914-925.
30. Rashid W., Parkes L.M., Ingle G.T., Chard D.T., Toosy A.T., Altmann D.R., Symms M.R., Tofts P.S., Thompson A.J., Miller D.H. Abnormalities of cerebral perfusion in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2004, 75:1288-1293.
31. Rindfleisch, E., 1872. Pathological histology: an introduction to the study of pathological anatomy. Translated by WC Klonan and FT Miles. Trubner and Co., London, 652-658.
32. Risau W., Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol. 1988, 125:441-450.
33. Roscoe W.A., Welsh M.E., Carter D.E., Karlik S.J. VEGF and angiogenesis in acute and chronic MOG (35-55) peptide induced EAE. J. Neuroimmunol. 2009, 209:6-15.
34. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 2002, 39:279-291.
35. Seabrook T.J., Littlewood-Evans A., Brinkmann V., Pollinger B., Schnell C., Hiestand P.C. Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J. Neuroinflammation 2010, 7:95.
36. Silva R., D'Amico G., Hodivala-Dilke K.M., Reynolds L.E. Integrins: the keys to unlocking angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1703-1713.
37. Stowe A.M., Altay T., Freie A.B., Gidday J.M. Repetitive hypoxia extends endogenous neurovascular protection for stroke. Ann. Neurol. 2011, 69:975-985.
38. Tonnesen M.G., Jenkins D., Siegal S.L., Lee L.A., Huff J.C., Clark R.A. Expression of fibronectin, laminin, and factor VIII-related antigen during development of the human cutaneous microvasculature. J. Invest. Dermatol. 1985, 85:564-568.
39. Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009, 8:280-291.
40. Wang P., Xie Z.H., Guo Y.J., Zhao C.P., Jiang H., Song Y., Zhu Z.Y., Lai C., Xu S.L., Bi J.Z. VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2011, 411:620-626.
41. Wei L., Erinjeri J.P., Rovainen C.M., Woolsey T.A. Collateral growth and angiogenesis around cortical stroke. Stroke 2001, 32:2179-2184.
42. Welser J., Li L., Milner R. Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1. J. Neuroinflammation 2010, 7:89.
43. Wuerfel J., Bellmann-Strobl J., Brunecker P., Aktas O., McFarland H.F., Villringer A., Zipp F. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004, 127:111-119.
44. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2001, 2:502.
45. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.